Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC
The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share.
Shelter Pharma Limited has secured a noteworthy order from FIRSTVET Veterinary Medicines Trading LLC, an international entity based in Dubai, for Lactic Acid Buffer Bottles. This fixed-cost order, valued at USD 23,000, requires Shelter Pharma Limited to execute the delivery within two months.
Shelter Pharma Limited is a prominent pharmaceutical and nutraceutical company renowned for its dedication to research, innovation and quality. Established to provide accessible and effective healthcare solutions, the company has consistently delivered products that meet the highest industry standards. Their state-of-the-art facilities, world-class team of experts and commitment to ethical practices have earned them a reputation of trust in the industry. Shelter Pharma's mission is to promote well-being and health through innovative, high-quality nutraceuticals.
On Thursday, shares of Shelter Pharma Ltd surged 8.66 per cent to Rs 57.60 per share from its intraday low of Rs 53.01 per share. The stock’s 52-week high is Rs 80.90 per share and its 52-week low is Rs 41.01 per share. The stock falls under S&P BSE SME IPO with a lot size of 3,000 shares.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
The company has a market cap of Rs 66 crore. The company’s current debt is Rs 0.57 crore which is less than 1 per cent of the market cap. The promoters own more than half of the company's shares, with 54.97 per cent while the general public owns the rest, with 45.03 per cent as of September 2024. There are 1,119 public shareholders as of September 2024.
The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share.
Disclaimer: The article is for informational purposes only and not investment advice.